LLY vs PFE: six-factor score, head to head
How Eli Lilly & Co. and Pfizer Inc.compare on Tapeline’s published six-factor composite score. Descriptive only — a rules-based reading of each name, not a recommendation.
Today, LLY scores 66 and PFE scores 55on Tapeline’s six-factor composite. LLY carries the higher composite score today. Here’s how the six factors line up.
| Factor | LLY | PFE |
|---|---|---|
| Trend | 91 | 88 |
| Relative Strength | 66 | 37 |
| Fundamentals | 83 | 59 |
| Smart Money | 11 | 17 |
| Macro | 75 | 75 |
| Momentum | 50 | 30 |
LLY · Health Care
fundamentals factor above the score midpoint; relative-strength factor on the lower side vs healthcare peers.
PFE · Health Care
fundamentals factor on the upper side of its range.
The Tapeline Score is a descriptive, rules-based measure for information only — not investment advice or a recommendation to buy or sell. See the six-factor method and the public scorecard.
More comparisons
FAQ
- How do LLY and PFE compare on Tapeline?
- Tapeline scores LLY 66/100 and PFE 55/100 on its published six-factor composite (trend, relative strength, fundamentals, smart money, macro, momentum). The page breaks the two scores down factor by factor.
- Which has the higher Tapeline score, LLY or PFE?
- LLY has the higher composite score today (66 vs 55). The score is a descriptive measure, not a recommendation — see the per-factor breakdown above.
- Is this investment advice?
- No. Tapeline publishes a descriptive, rules-based six-factor score for information only. It is not a recommendation to buy or sell, and every top pick is back-checked publicly at /scorecard.